Policymaking: Key Political and Business Developments in April 2026
This Axios briefing highlights critical policymaking developments across politics, business, and technology as of April 15, 2026. In the political sphere, Democrats are strategizing following failed war powers legislation regarding Iran, while relations between Israel and Congressional Democrats reach a low point. Legislative actions include a long-shot 25th Amendment bill targeting President Trump and Senate plans to scrutinize Cabinet officials on the federal budget. Concurrently, funding cuts and political disputes are complicating the administration's response to the 'Mythos' situation. In the business sector, regulators have vowed to investigate insider trading within prediction markets, and Hollywood stakeholders are exerting pressure on the Paramount Skydance merger. Health policy faces challenges as state efforts to regulate Pharmacy Benefit Managers (PBMs) encounter legal obstacles. On the global stage, concerns mount over the potential economic impact of the Iran war, while Europe continues to refine its AI regulatory framework, prioritizing guardrails before flexibility. These stories collectively illustrate a complex landscape of legislative gridlock, regulatory enforcement, and geopolitical tension affecting domestic and international policy.
Wire timeline
Policymaking: Key Political and Business Developments in April 2026
This Axios briefing highlights critical policymaking developments across politics, business, and technology as of April 15, 2026. In the political sphere, Democrats are strategizing following failed war powers legislation regarding Iran, while relations between Israel and Congressional Democrats reach a low point. Legislative actions include a long-shot 25th Amendment bill targeting President Trump and Senate plans to scrutinize Cabinet officials on the federal budget. Concurrently, funding cuts and political disputes are complicating the administration's response to the 'Mythos' situation. In the business sector, regulators have vowed to investigate insider trading within prediction markets, and Hollywood stakeholders are exerting pressure on the Paramount Skydance merger. Health policy faces challenges as state efforts to regulate Pharmacy Benefit Managers (PBMs) encounter legal obstacles. On the global stage, concerns mount over the potential economic impact of the Iran war, while Europe continues to refine its AI regulatory framework, prioritizing guardrails before flexibility. These stories collectively illustrate a complex landscape of legislative gridlock, regulatory enforcement, and geopolitical tension affecting domestic and international policy.
axios